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n&O (c. pncumor~?e) causes coronary artery d~seasu. There are saverat 
reports that Ihe argantrm IR found m diseased but no1 normal coronary ar. 
lanes. For the hrs;l time. wo have studied whole segments of diseased and 
norm%1 blood vesnets (mm IN0 paltents 
Method’ From 38 paltonls undergoing redo and 9 patients undergoing 
lust bmo cotonety artery byp%es graft aurgmy. tntmls ot occluded venous 
graft% Of %lh%f@&tny Ot tl%tiv% rZoRXl%rY veS%el% were obtained along with 
eegments ot nonni?l saphenous vem and int%m%l tnammmy arteery (IMA) G. 
pneumon& DNA w%% ctwcked tot by tC @ytnof%8% chain m%ctkm (PCR) 
conctusKrm c mae is unfikety to ke a direr3 cause of athefoacfe- 
fosrs as tt 1s kxmcl Ihra@o@ the ~scdar k?e fncfcadmg fhe IMA whrch IS not 
assoccated wtth a!heroecterosis. Nowever. we have not ruled oul an tndx%ct 
el?ect such as increasmg the cwagulalnlty of b!ood ur mat It ex,acecbates 
Pm-eXlstmq ptaques 
lzzl 1064 9 Risk Factors in +TMm Populations at ContrastIng 
Risk for Coronary Amy Diise 
J. Fetires. A. Evans. P. Anxxiyel. D. Awetler, J. Yamell. J 8. Awdaveb. 
I-J. Vague. J.C. Fruchart. G. Luc. PY. Scarabm. F Cambten, P Ducrmetlere. 
Cam De@Tmenl CtfU Purpan. fb&use. France 
Backgruuncf. The mctdence ot coronary artery disease (CAD) m m&lbagea 
men IS more than three bees higner m Not-Wrn Ireland than m France. The 
PRIME Stu@y, based on WHO MONICA Centers in Belfast (Northern treland, 
2748 men), U!te (Nonhem France. 2627 men). Strasbourg (Eastem France. 
2611 men) andToutousa(Sauthwestem France, 261Omen). rsacohortstudy 
m which we pian to analyze the m+tirtco of CAD nsk factors m men aged 
4S-KI years over a penod ot 5 years 
Meethcds: We compared the nsk factor level between 451 CAD subfects 
(prewous myocardial mtarchon or angma) al entry and 10145 &as&me 
subtects Ctkxcal variable-s (age. body mass index. b&d pressure. cigarette 
smokmg. diabetes melktus. alconol consumptron). fibrinogen levels and an 
u+&plh SALK& 01 l~pcl vanables [total cholesterol. tnglycende. HDL choles- 
terol, apokpopmtem (ape) At, apo 8, kpoprotem parttcle (Lp) Al. Lpa (a) Lp 
BE) were analyzed m this p:t?valence case-conrrol study 
ResurSr After aqustement for age. body mass index. blood pressure level. 
crgarette smokmg. dtab-etes and alcohol consumption. m Norlhem Ireland and 
France, patients m comparison wtth controls (p _ 0.01) had lower levels of 
HDL cholesterol. apo Al. Lp At and hrgher levels 01 fibrinogen. mgfY.Xride. 
apo 8. Lp BE and Lp (a). In two countnes wrth stnkmg dtfferences In CAD 
nsk. differences between cases and contmls were srmllar. However. Lp (a). 
Lp 6:E and fibrinogen levels were htgher and Lp Al levels were tower m 
Northern lnsh than tn French contmls (p q 0.001). 
Cotiusron: These results could explam part of the larp excess of CAD 
observed m Northern Ireland and the prospectwe pan of Ihe study will permet 
to quanttfy 11. 
\1064-10 ] Enhanced Expression of Endothelin-Converting 
Enzyme Is Associated With the Pmgression of 
Coronary Aiherosclemsis in Humans 
Takahiko Naruko. Makiko Ueda. Kazuo Haze. Allard C. van der Wal. Chris 
M. van der Loos. Kazuhlko Tanzawa. Antol, E. Becker. O&a Cify Genera/ 
Hospffal. Osaka. Japan; Academic Med;ca/ Center. Amsterdam. The 
NerheCnds 
Background: Endolhelin-1 is a potent vasoconslrictor and presents a mlto- 
genie ac’ vity on vascular smoath muscle cells (SMC). Endothelmconvertmg 
e.?:yme (ECE) is the final key enzyme al endathelin-1 processing. We stud- 
ied the expression of ECE in human coronary athemsclemlrc lestons. using 
immunoc@chemical techniques. 
Methods: Fmzen sections. normal with diffuse intimal thickening (DIT; n 
= 23). and diseased, with early alherosclemtlc plaques (early AP: n = 6). 
and advanced atherosclerotic plaques (advanced AP: n = 18) were studied. 
Monoclonal antibodies were directed against SMC. macrophages (Ma). en- 
dothelial cells (EC), and ECE (AEC32-236). For the identification of cell types 
which express ECE, the immunodouble staining method was alS0 used. 
Moteculsr and Gfmatic Studka of uptd 
DI~ORIWQI 
MCVtelay, March 30. 1998,3:00 p.m,d:OO pm, 
(4eof9ia World Gonqress Gentar. Wea Exhibit Hall Lswl 
Preslentalian Hour: 3:OO p.m.--400 p.m. 
We haM rdenbfii 4 famtty rn New York Slate wttt mulatrons in both the 
llpoprofeln kpase (LPLJ gene and %pol@opmtam (ape) A-l gene. A -Q3TiG 
-tin n the LPL pornofor regcon was &nt&xl in 0 tamtly members. 
In addition. 2 ptewously umapocted mutations m ttw LPL promotor rem. 
~634Mand -755 G/Asegregeted withthe -93 TKi transitron mefl%tiected 
sub(ects. A bas+p%ir substiiutmn m Me apoA-I gene (Phe” - Tyr) was al%0 
rdenttfti m 12 biologtc tamiiy members. Mean levets ot Itp@s. iiins 
and apolipopmtetm m subpxts w#h the LPL vanants or ApoA-I Ptattsburgh 
(Phe” -TV) compared to unafiected family members (controls, n = 16) are 
shown m the Tabte Compared IO controls. sub@cts Wm, the LPL vanants had 
stgnrfcantty lower HDL-C (p = 0.03) and apoA-I (p = 0.03). Apia_I Platt%&urgh 
was -ated mth s&!ndrc%ntly tower HDLC (p = 0.02). The proband wnh 
%poA-I Plattsburgh (TC = 192 m$lL HDLG = 6 mg/dL. apuA-I = 24 nTg@LJ 
developed CAD at age 44 ym. Premature CAD also occumzd m assock?tion 
wlm the LPL promotor vanant. These data demonstrate that HDL-C may be 
mlluertced by more th%n one major gene candrdare wrthrn the same famdy 
and that vanants m the LPL promotor regton contribute lo low HDLG 
Mutanan TC HOL LOL TG A&MA-I AWB 
LPL 931.” 203 34 143 155 86 z- 
np0A.l 174 3i) 103 121 116 106 
COnfrOlS 199 47 128 186 127 e9 
]1065-12 Llpopmtein Lipese Gene Polymorphisms Are 
Predictors of Risk of Coronary Artery Disease 
and Myocardbl Infarclion 
J.l_ Anderson. G.J. Kmg. S.P. Elmer. T.L Barr. J.B Muhlestein. 
J.F. Carlquiet. LDS Hosprfal. Unrvem~ly of Utah S%/I Lake C@! Utah uSA 
&&ground Lrpoprotein llpase (LPLJ plays a cenlral rola m lipfd metabolism. 
hydmtyzmg tnglycende in chylomrcrons anu VLDL. Common polymorphc 
vanants of the LPL gene have recently been rdentltkzd. Those defmed by 
the Hrcdili and pvull restnctron sttes may alter plasma ltptds. We @sW 
whether the* LPL potymorpttphimrs - wtrcaw. the ten common%llde(-J 
or the homozygous genotype (--I-) - mtght be PrediCtOfS Ot InCTeaSd n9k 
tw -2ry artery tttsease (CAD) and mywrdral &KZF~K~? (f&J. 
Metnods: Blood was drawn tmm 1067 Conseclnhre corIsemlng Pt un. 
dergotng coronary angmgraphv Segments contammg Ihc site ln lntmn 8 (“1 
I 067) and the site m mhon 6 (nt 685) were ampllticd by the potV6nsc Cha’n 
reactton and dIgested. Polymorphrsms Were ldentltied aner el~~~s’s 
m t .5?!, agamse gel and staining with ethidium bmm@e. 
&su!B: Frequencres ot the (-) allele were 41.9’&. 43.690 for ml end 
27.30~. 27.496 for ~;ndJll in non-GAD (C 10% stenosrs) and non-MI ContrOts. 
respectively. Genotype distributions conformed to Hardy-Wernkrg ema. 
lions; connob homomte (-I-) genotype frequencies were 18.3X 179”. 
jn the 2 ccntrofll groups. re+ily. For Pwull. the homozygote (-‘-J tm- 
quency was not imaged for MI (23.490. OR = 1.4. P = 0.1) Or CAD Pt 
(,609$ StenOsrs) (21 .po. OR = 1.17). overall or m men. However. the (-‘- 1 
oenome was increased (30~ LS is”&. OR -7 2.8. p . 0.008) In women wth 
